Skip to main content
logo
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
8.19
+0.01 (0.12%)
At close: Aug 6, 2025, 4:00 PM
8.40
+0.21 (2.56%)
After-hours: Aug 6, 2025, 7:49 PM EDT

Kronos Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Market Capitalization
7302579942,448--
Upgrade
Market Cap Growth
62.93%-74.11%-59.40%---
Upgrade
Enterprise Value
527266442,292--
Upgrade
Last Close Price
8.193.7814.7236.95--
Upgrade
PE Ratio
--20.17---
Upgrade
Forward PE
--16.68---
Upgrade
PS Ratio
-573.952.952.61110.13--
Upgrade
PB Ratio
3.621.562.297.19--
Upgrade
P/TBV Ratio
3.621.562.297.19--
Upgrade
P/FCF Ratio
--93.08---
Upgrade
P/OCF Ratio
--83.39---
Upgrade
EV/Sales Ratio
-0.291.69103.12--
Upgrade
EV/EBITDA Ratio
--16.13---
Upgrade
EV/EBIT Ratio
--16.59---
Upgrade
EV/FCF Ratio
--60.27---
Upgrade
Debt / Equity Ratio
0.010.010.010.02-0.27
Upgrade
Debt / EBITDA Ratio
--0.10---
Upgrade
Debt / FCF Ratio
--0.40---
Upgrade
Asset Turnover
-0.250.840.090.010.08
Upgrade
Inventory Turnover
--6.39---
Upgrade
Quick Ratio
11.406.235.027.785.531.76
Upgrade
Current Ratio
12.056.675.668.206.031.86
Upgrade
Return on Equity (ROE)
-83.24%-100.88%12.73%-92.53%-188.05%-
Upgrade
Return on Assets (ROA)
-40.72%-51.31%5.34%-50.63%-86.34%-281.44%
Upgrade
Return on Capital (ROIC)
-48.86%-60.36%6.18%-57.85%-108.86%-1215.56%
Upgrade
Return on Capital Employed (ROCE)
--8.90%---
Upgrade
Earnings Yield
-29.98%-117.25%4.96%-8.10%--
Upgrade
FCF Yield
-33.32%-79.27%1.07%-7.45%--
Upgrade
Buyback Yield / Dilution
-7.53%2.64%-19.65%-788.13%-8.37%-3.20%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q